ReviewAMB Express2025
Advances in semi-rational design of terpene synthases and their modifying enzymes.
Review in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered microorganisms unlock a new era of diterpenoid biomanufacturing: recent advances and future perspectives.Bioresources and bioprocessing · 2026Review
- The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology.Journal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
As research on natural terpene compounds advances, their pharmacological properties and commercial potential are increasingly recognized. Microbial cell factories offer an efficient means of producing high-value terpene natural products through biosynthesis. However, inherent limitations of native enzymes, such as low catalytic activity and poor stability, have constrained further improvements in production capacity. Recent progress in bioinformatics and the availability of detailed enzyme crystal structures have made semi-rational design a viable and powerful strategy for enhancing the catalytic performance of terpene synthases. This review summarizes semi-rational design strategies applied to key enzymes in the biosynthetic pathways of various terpenes, including mono-, sesqui-, di-, tri-, and tetraterpenes, as well as modifying enzymes such as cytochrome P450s, glycosyltransferases, acetyltransferases, ketolases and hydroxylases involved in terpene biosynthesis. By highlighting recent advances in the functional application of beneficial mutations, it offers a framework for optimizing the catalytic efficiency of enzymes within terpene biosynthesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.